Language selection

Search

Tuberculosis in developing countries

Tuberculosis (TB) is a contagious and bacterial airborne disease. It is the world’s leading infectious diseases killer. According to the World Health Organization (WHO), around 1.8 billion people are infected with TB, most of whom have the inactive form of the disease. In 2024, an estimated 10.7 million people fell ill with TB. Of this number:

People living with HIV/AIDS are 16 times more likely to develop TB due to a weakened immune system. TB is the leading cause of death among people with HIV. In 2024, TB caused:

TB causes a high number of deaths despite being a preventable and curable disease due in large part to the fact that globally more than 4 million people who developed TB per year are being missed by public health systems.

Finding the missing cases

These missed people do not receive the treatment and care they need. Many of these untreated cases occur in vulnerable and at risk populations due to:

People who have untreated TB are more likely to infect others. Key groups at risk include:

The COVID-19 pandemic  had a profound impact on TB. It posed great challenges to TB control and elimination efforts worldwide. The pandemic has led to setback in TB control progress because of:

 COVID-19 measures such as lockdowns and social distancing, hindered TB case detection and treatment adherence.

Addressing the impacts  that  COVID-19 had on our ability to address TB requires:

Canada's priorities

The international community, including Canada, has agreed to end TB by 2030. It is one of the targets set out in the UN's Sustainable Development Goals. Canada and other countries reaffirmed this commitment in 2023 at the UN General Assembly High-Level Meeting on the fight against tuberculosis, which was the second UN high-level meeting on TB. Canada recognizes the urgent need to control TB.

Canada's global priorities on TB include:

Canada's engagement

The Stop TB Partnership, founded in 2001, is a key partner of Canada in the fight against TB. Established as a global coordinating mechanism, its objective is to motivate and facilitate global efforts to stop the spread of TB. The Stop TB Partnership works closely with many other key TB stakeholders. Canada is a member of the organization's Board and Executive Committee.

TB REACH is an initiative under the Stop TB Partnership. Launched in 2010, TB REACH supports innovative projects. Its goal is to improve the detection and treatment of TB in targeted vulnerable populations, including women and girls. Canada has committed $241.5 million since 2010, including $25.5 million for the period from 2023 to 2027, making Canada a leading contributor to the TB REACH initiative. Canada's support to TB REACH has contributed to the detection and treatment of nearly 3 million people with TB. It has further prevented more than 15 million new infections.

Canada also supports the Global Fund to Fight AIDS, Tuberculosis and Malaria (also known as the Global Fund). Canada is the Global Fund's sixth largest donor. Since its creation in 2002, Canada has committed over $5.4 billion to the organization, including the latest pledge of $1.02 billion for the 2026 – 2028 period, making it Canada’s largest annual health investment. Approximately 18% of the Global Fund's financing goes toward fighting tuberculosis. In 2024, the Global Fund treated 7.4 million people with TB. To this day, the Global Fund continues to invest heavily in improving case detection, diagnosis and treatment.

Date modified: